:::

詳目顯示

回上一頁
題名:以追求身心完美為名:生活機能醫藥對健康照護的危害
書刊名:臺灣公共衛生雜誌
作者:丁志音劉芳助李袖瑜
作者(外文):Lew-Ting, Chih-yinLiu, Fang-zhuLi, Hsiu-yu
出版日期:2007
卷期:26:6
頁次:頁443-451
主題關鍵詞:生活機能醫藥健康強化科技健康照護牟利化醫療化Lifestyle medicinesHealth enhancement technologyProfitalization of health careMedicalization
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(2) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:8
  • 點閱點閱:38
期刊論文
1.丁志音(19990400)。醫師如何看待醫院的企業化經營管理趨勢。中華公共衛生雜誌,18(2),152-166。new window  延伸查詢new window
2.McArthur, J. H.、Moore, F. D.(1997)。The two cultures and the health care revolution: Commerce and professionalism in medical care。JAMA,277,985-989。  new window
3.Miller, F. G.、Brody, H.(2005)。Enhancement technologies and professional integrity。Am J Bioethics,5,15-17。  new window
4.Bostrom, Nick(2005)。In Defense of Posthuman Dignity。Bioethics,19(3),202-214。  new window
5.Conrad, Peter(1975)。The Discovery of Hyperkinesis: Notes on the Medicalization of Deviant Behavior。Social Problems,23(1),12-21。  new window
6.Lexchin, J.(2006)。Bigger and Better: How Pfizer Redefined Erectile Dysfunction。PLoS Medicine,3,132。  new window
7.Kapiriri, L.、Martin, D. K.(2007)。Bedside Rationing by Health Practitioners: A Case Study in a Ugandan Hospital。Medical Decision Making,27,44-52。  new window
8.Parens, E.(2005)。Authenticity and Ambivalence: Toward Understanding the Enhancement Debate。The Hastings Center Report,35,34-41。  new window
9.Emanuel, L.(1997)。Bringing Market Medicine to Professional Account。JAMA: The Journal of the American Medical Association,277,1004-1005。  new window
10.Mehlman, M. J.(2004)。Cognition-enhancing Drugs。The Milbank Quarterly,82,483-506。  new window
11.WHO(2006)。Counterfeit Medicines。WHO Drug Information,20,3-4。  new window
12.Ashworth, M.、Clement, S.、Wright, M.(2002)。Demand, Appropriateness and Prescribing of 'Lifestyle Drugs': A Consultation Survey in General Practice。Family Practice,19,236-241。  new window
13.Mansfield, P. R.、Mintzes, B.、Richards, D.(2005)。Direct to Consumer Advertising Is at the Crossroads of Competing Pressures from Industry and Health Needs。British Medical Journal,330,5-6。  new window
14.Hoffman, J. R.、Wilkes, M.(1999)。Direct to Consumer Advertising of Prescription Drugs: An Idea Whose Time Should Not Come。British Medical Journal,318,1301-1302。  new window
15.Murray, E.、Lo, B.、Pollack, L.、Donelan, K.(2003)。Direct-toconsumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor-patient Relationship。Journal of the American Board Practice,16,513-524。  new window
16.Bell, R. A.、Kravitz, R. L.、Wikes, M. S.(1999)。Direct-to-consumer Prescription Drug Advertising and the Public。Journal of General Internal Medicine,14,651-657。  new window
17.Holmer, A. F.(1999)。Direct-to-Consumer Prescription Drug Advertising Builds Bridges between Patients and Physicians。JAMA: The Journal of the American Medical Association,281,380-382。  new window
18.Hogle, L. F.(2005)。Enhancement Technologies and the Body。Annual Review of Anthropology,34,695-716。  new window
19.Wick, J. Y.(2002)。Enhancing Life or Eradicating Ugliness? Lifestyle Drugs。Journal of Managed Care Pharmacy,8,15-20。  new window
20.DeCamp, M.(2002)。Ethics and the Physician-patient Relationship: Medico-moral Consequences of Commodification。Einstein Quarterly Journal Medicine,19,135-138。  new window
21.(1998)。Go on, It's Good for You [Editorial]。The Economist,348,51-52。  new window
22.Mintzes, B.、Barer, M. L.、Kravitz, R. L.(2003)。How Does Direct-to-consumer Advertising (DTCA) Affect Prescribing? A Survey in Primary Care Environments with and without Legal DTCA。Canadian Medical Association Journal,169,405-412。  new window
23.Smith, R.(2002)。Insearch of "Non-disease"。British Medical Journal,324,883-885。  new window
24.Garg, R. K.、Khaishgi, A.、Dandona, P.(1999)。Is Management of Impotence with Sildenafil Changing Clinical Practice?。The Lancet,353,375-376。  new window
25.Atkinson, T.(2002)。Lifestyle Drug Market Booming。Nature Medicine,8,909。  new window
26.Young, S. N.(2003)。Lifestyle Drugs, Mood, Behavior and Cognition。Journal of Psychiatry & Neuroscience,28,87-89。  new window
27.Mitrany, D.(2001)。Lifestyle Drugs: Determining Their Value and Who Should Pay。Pharmacoeconomics,19(1/2),441-448。  new window
28.Lexchin, J.(2001)。Lifestyle Drugs: Issues for Debate。Canadian Medical Association Journal,164(10),1449-1451。  new window
29.Flower, R.(2004)。Lifestyle Drugs: Pharmacology and the Social Agenda。Trends in Pharmacological Sciences,25,182-185。  new window
30.Gilbert, D.、Walley, T.、New, B.(2000)。Lifestyle Medicines。British Medical Journal,321,1341-1344。  new window
31.Walley, T.(2002)。Lifestyle Medicines and the Elderly。Drugs and Aging,19,163-168。  new window
32.Phillips, C. B.(2006)。Medicine Goes to School: Teachers as Sickness Brokers for ADHD。PLoS Medicine,3,182。  new window
33.Martin, Emily(2000)。Mind-body Problems AES Presidential Address: Mind-body Problems。American Ethnologist,27(3),569-590。  new window
34.Deckard, G. J.(1995)。Physician Responses to a Managed Environment: A Perceptual Paradox。Health Care Management Review,20,40-46。  new window
35.Ubel, P. A.、Goold, S.(1997)。Recognizing Bedside Rationing: Clear Cases and Tough Calls。Archives of Internal Medicine,126,74-80。  new window
36.Moynihan, R.、Heath, I.、Henry, D.、Gotzsche, P. C.(2002)。Selling Sickness: The Pharmaceutical Industry and Disease Mongering Commentary: Medicalisation of Risk Factors。British Medical Journal,324,886-891。  new window
37.Relman, A. S.(1983)。The Future of Medical Practice。Health Affairs,2,5-19。  new window
38.Frankel, S.、Ebrahim, S.、Davey, Smith G.(2000)。The Limits to Demand for Health Care。British Medical Journal,321,40-45。  new window
39.Relman, A. S.(1980)。The New Medical-industrial Complex。The New England Journal of Medicine,303,963-970。  new window
40.Møldrup, C.(2004)。The Use of the Terms 'Lifestyle Medicines' or 'Lifestyle Drugs'。Pharmacy World and Science,26,193-196。  new window
41.Moynihan, R.、Smith, R.(2002)。Too Much Medicine: Almost Certainly。British Medical Journal,324,859-860。  new window
42.Klein, R.、Sturm, H.(2002)。Viagra: A Success Story for Rationing?。Health Affairs,21,177-187。  new window
43.Overman, S.(1998)。Warning: Viagra May Cause Headaches for Health Insurers。Human Resources Magazine,43,104-109。  new window
學位論文
1.吳家勳(2005)。醫院自費醫療服務經營之調查研究(碩士論文)。元智大學。  延伸查詢new window
2.宋奉宜(2003)。公立醫院自費醫療服務之績效評估--以某醫學美容中心為例(碩士論文)。長庚大學。  延伸查詢new window
圖書
1.Illich, I.(1975)。Medical Nemesis: The Expropriation of Health。New York:Pantheon Books。  new window
2.Haiken, E.(1999)。Venus Envy: A History of Cosmetic Surgery。Baltimore, MD:The Johns Hopkins University Press。  new window
3.Gilbert, D.(1999)。Lifestyle Drugs: Who Will Pay? Scrip Report。London, UK:PJB Publications。  new window
4.Reuters Business Insight(2002)。Lifestyle Drugs Outlook to 2007: Challenges and Opportunities in a High-profile Growth Market--New Strategic Management Report。London, UK:Reuters。  new window
5.Elliott, C.(2003)。Better than Well: American Medicine Meets the American Dream。New York, NY:W. W. Norton & Company。  new window
6.The President's Council on Bioethics(2003)。Beyond Therapy: Biotechnology and the Pursuit of Happiness。New York, NY:Regan Books。  new window
7.Rothman, S. M.、Rothman, D.(2003)。The Pursuit of Perfection: The Promise and Perils of Medical Enhancement。New York, NY:Pantheon Books。  new window
其他
1.Patel, H.(2000)。Lifestyle drugs,http://www.caremarkxom, 2000/07/31。  new window
2.Internet communication(2003)。Lifestyle drugs: potion for growth,http://www.Equitymaster.com, 2003/08/10。  new window
3.Kole, P. L.,Bhusari, S.,Thakurdesai, P. A.(2003)。Lifestyle drugs: new avenues,http://www.Equitymaster.com, 2003/08/10。  new window
4.(20060608)。打擊偽藥藥廠出招。  延伸查詢new window
5.胡宗鳳(20060927)。生育率低婦科跨做美容醫學。  延伸查詢new window
6.李樹人(20060709)。向錢衝!骨科、小兒科醫師學雷射。  延伸查詢new window
7.劉梅君,林志鴻(20060112)。醫療階級化儼然成形,健保的公平正義遭侵蝕。  延伸查詢new window
圖書論文
1.Mackintosh, M.、Koivusalo, M.(2005)。Health Systems and Commercialization。Commercialization of Health Care: Global and Local Dynamics and Policy Responses。Basingstoke, UK:Palgrave Macmillan。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top